| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| jnj-10311795 | chymase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Chronic Obstructive Airway Disease[MeSHID:D029424] |
63.65 | phase 2 | inhibitor |
| jnj-10311795 | chymase | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Chronic Obstructive Airway Disease[MeSHID:D029424] |
63.65 | phase 2 | unknown |
| jnj-10311795 | cathepsin g | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Chronic Obstructive Airway Disease[MeSHID:D029424] |
10.61 | phase 2 | unknown |
| click here to return to the previous page | ||||||||